|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61P 35/00 | (2006.01) |
| G01N 33/57484 | (2013.01) | ||
| C12Q 1/6886 | (2018.01) | ||
| G01N2800/52 | (2013.01) | ||
| G01N 33/53 | (2006.01) | ||
| C12Q 1/6886 | (2013.01) | ||
| C12Q2600/106 | (2013.01) | ||
| C12Q2600/158 | (2013.01) | ||
| A61P 35/00 | (2018.01) |
| (11) | Number of the document | 3383496 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16871597.7 |
| Date of filing the European patent application | 2016-12-02 | |
| (97) | Date of publication of the European application | 2018-10-10 |
| (45) | Date of publication and mention of the grant of the patent | 2022-05-25 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2016/064679 |
| Date | 2016-12-02 |
| (87) | Number | WO 2017/096201 |
| Date | 2017-06-08 |
| (30) | Number | Date | Country code |
| 201562262242 P | 2015-12-02 | US |
| (72) |
MILES, Linde , US
POIRIER, John , US
RUDIN, Charles , US
|
| (73) |
Memorial Sloan-Kettering Cancer Center ,
Office of Technology Development
1275 York Avenue
Box 524, New York, NY 10065,
US
|
| (54) | SENECA VALLEY VIRUS (SVV) CELLULAR RECEPTOR TARGETED ONCOTHERAPY |
| SENECA VALLEY VIRUS (SVV) CELLULAR RECEPTOR TARGETED ONCOTHERAPY |